Xylem Inc. $XYL Shares Sold by Goldman Sachs Group Inc.

Key Points

• Goldman Sachs Group Inc. has reduced its stake in Xylem Inc. by 7.1%, totaling approximately $272 million after selling 174,835 shares.
• Xylem announced a quarterly dividend of $0.40 per share, scheduled to be paid on September 25th, with a yield of 1.2%.
• The company reported a 6.1% year-over-year increase in revenue for the last quarter, growing to $2.30 billion and exceeding analysts' expectations.

Goldman Sachs Group Inc. reduced its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 7.1% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,278,333 shares of the industrial products company's stock after selling 174,835 shares during the period. Goldman Sachs Group Inc. owned approximately 0.94% of Xylem worth $272,170,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in XYL. Valley National Advisers Inc. lifted its stake in shares of Xylem by 84.9% during the first quarter. Valley National Advisers Inc. now owns 220 shares of the industrial products company's stock worth $26,000 after buying an additional 101 shares during the period. Perkins Coie Trust Co acquired a new stake in shares of Xylem during the first quarter worth $27,000. Center for Financial Planning Inc. lifted its stake in shares of Xylem by 52.0% during the first quarter. Center for Financial Planning Inc. now owns 266 shares of the industrial products company's stock worth $32,000 after buying an additional 91 shares during the period. Heck Capital Advisors LLC acquired a new stake in shares of Xylem during the fourth quarter worth $36,000. Finally, Headlands Technologies LLC lifted its stake in shares of Xylem by 90.6% during the first quarter. Headlands Technologies LLC now owns 305 shares of the industrial products company's stock worth $36,000 after buying an additional 145 shares during the period. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Xylem Stock Down 1.8%

XYL opened at $137.48 on Wednesday. The company has a fifty day moving average of $137.70 and a two-hundred day moving average of $127.36. The stock has a market capitalization of $33.46 billion, a price-to-earnings ratio of 35.71, a PEG ratio of 2.42 and a beta of 1.09. Xylem Inc. has a fifty-two week low of $100.47 and a fifty-two week high of $145.33. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.43 and a current ratio of 1.90.

Xylem (NYSE:XYL - Get Free Report) last posted its earnings results on Thursday, July 31st. The industrial products company reported $1.26 EPS for the quarter, beating analysts' consensus estimates of $1.15 by $0.11. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The firm had revenue of $2.30 billion for the quarter, compared to analysts' expectations of $2.20 billion. During the same period last year, the firm earned $1.09 EPS. The company's quarterly revenue was up 6.1% on a year-over-year basis. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. On average, research analysts expect that Xylem Inc. will post 4.65 earnings per share for the current year.

Xylem Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend is Thursday, August 28th. Xylem's dividend payout ratio (DPR) is presently 41.56%.

Insider Buying and Selling

In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm's stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $139.96, for a total value of $139,960.00. Following the sale, the chief accounting officer directly owned 2,957 shares of the company's stock, valued at approximately $413,861.72. This trade represents a 25.27% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.27% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have recently commented on XYL. Citigroup reiterated a "buy" rating and set a $152.00 price objective (up from $137.00) on shares of Xylem in a research note on Monday, July 14th. TD Cowen raised their target price on shares of Xylem from $125.00 to $130.00 and gave the stock a "hold" rating in a report on Tuesday, August 26th. Raymond James Financial raised shares of Xylem to a "hold" rating in a report on Thursday, May 15th. Wall Street Zen raised shares of Xylem from a "hold" rating to a "buy" rating in a report on Saturday, August 9th. Finally, Stifel Nicolaus raised their target price on shares of Xylem from $162.00 to $175.00 and gave the stock a "buy" rating in a report on Friday, August 1st. Six equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $152.29.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.